Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
30–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Radical prostatectomy for prostate cancer within last 2 months.
Post-operative Kattan nomogram predicts \>25% risk of PSA relapse by 5 years.
6-week post-operative serum PSA\<0.2ng/mL.
Low levels of circulating prostate cancer cells in the blood, detected by PCR amplification of PSA mRNA 6 weeks post-prostatectomy.
You may not be if
Pre-operative serum PSA level \>20ng/ml.
Clinical evidence of metastases by 6-week post-operative visit.
Prior treatment with either ADT or bisphosphonate therapy.
Current active dental problems including infection of the teeth or jawbone (maxilla or mandibular); dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw (ONJ), of exposed bone in the mouth, or of slow healing after dental procedures.
Recent (within 6 weeks) or planned dental or jaw surgery (e.g.extraction, implants)
Clareo Health | Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.
